• PDF / 166,910 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 71 Downloads / 184 Views

DOWNLOAD

REPORT

1173-5503/20/0867-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 28 Nov 2020 No. 867

1

Recommend Documents

NICE recommends apixiban and ranibizumab . . .

165 13 112KB

Dexamethasone/pomalidomide/trametinib

138 71 165KB

NICE recommends polatuzumab vedotin combination for DLBCL

185 46 163KB

NICE recommends Zio XT for detecting arrhythmias, with a caveat

182 15 163KB

NICE recommends caplacizumab for acute acquired TTP

149 71 163KB

NICE recommends osimertinib for advanced EGFR-positive NSCLC

159 54 163KB

NICE recommends BP monitor for atrial fibrillation detection

151 70 83KB

NICE recommends liraglutide & venetoclax + obinutuzumab, but not nivolumab

148 79 168KB

Pomalidomide

131 51 496KB

Lenalidomide/pomalidomide

148 45 167KB

Isatuximab: First Approval

155 69 891KB

Nice Numbers

192 57 12MB